Single-cell RNA sequencing to characterize the response of pancreatic cancer to anti-PD-1 immunotherapy

Single-cell RNA sequencing to characterize the response of pancreatic cancer to anti-PD-1 immunotherapy

Pancreatic cancer (PaC) is resistant to immune checkpoint therapy, but the underlying mechanisms are largely unknown. In this study, we have established four orthotopic PaC murine models with different PaC cell lines by intra-pancreatic inoculation. Therapeutic examinations demonstrate that only tum...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Jing Zhou, Yuexu Jiang, Yue Huang, Qiongling Wang, Jussuf T. Kaifi, Eric T. Kimchi, Chiswili Yves Chabu, Zhenguo Liu, Trupti Joshi, Guangfu Li
Format: article
Langue:EN
Publié: Elsevier 2022
Sujets:
Pancreatic cancer (PaC)
Single-cell sequencing (scRNA-seq)
Programmed cell death protein 1 (PD-1)
αPD-1 antibody (αPD-1 Ab)
Tumor-associated macrophages (TAM)
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Accès en ligne:https://doaj.org/article/a21934920a644ea9857ba22b86db5b6e
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/a21934920a644ea9857ba22b86db5b6e

Documents similaires